SUPERLUMINAL MEDICINES

LIVE

Serial Number

98212701

Owner

Superluminal Medicines, Inc.

Attorney

Gregory B. Coy

First Use Date

Feb 18, 2026

Filing Date

Oct 6, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SUPERLUMINAL MEDICINES Trademark

Serial Number: 98212701

SUPERLUMINAL MEDICINES is a trademark filed by Superluminal Medicines, Inc. on October 6, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Superluminal Medicines, Inc. (5 trademarks)

200 Berkeley Street, 18th Floor
Boston, MA 02116

Entity Type: 03

Legal Representation

Attorney of Record

Gregory B. Coy

551 trademarks filed View all →

Correspondence Address

Gregory B. Coy TAFT STETTINIUS & HOLLISTER LLP

One Indiana Square, Suite 3500

Indianapolis, IN 46204

United States

Trademark Details

Filing Date

October 6, 2023

Registration Date

Not Registered

First Use Anywhere

February 18, 2026

First Use in Commerce

February 18, 2026

Published for Opposition

July 9, 2024

Goods & Services

Development of pharmaceutical preparations and medicines

Pharmaceutical agents modulating high value protein targets such as G protein coupled receptors

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 10, 2026 GNRN

NON-FINAL ACTION E-MAILED

Jun 10, 2026 GNRT

SU - NON-FINAL ACTION - WRITTEN

Jun 10, 2026 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Jun 10, 2026 SUPC

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 24, 2026 EXRA

USE AMENDMENT FILED

Feb 23, 2026 IUAF

TEAS STATEMENT OF USE RECEIVED

Feb 23, 2026 EISU

SOU EXTENSION 3 GRANTED

Feb 23, 2026 EX3G

SOU EXTENSION 3 FILED

Feb 23, 2026 EXT3

SOU TEAS EXTENSION RECEIVED

Feb 23, 2026 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2025 EXRA

SOU EXTENSION 2 GRANTED

Aug 29, 2025 EX2G

SOU EXTENSION 2 FILED

Aug 29, 2025 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 29, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 4, 2025 EXRA

SOU EXTENSION 1 GRANTED

Mar 3, 2025 EX1G

SOU EXTENSION 1 FILED

Mar 3, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 3, 2025 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 3, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 9, 2024 NPUB

PUBLISHED FOR OPPOSITION

Jul 9, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 19, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 4, 2024 CNSA

EXAMINER'S AMENDMENT ENTERED

Jun 4, 2024 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 4, 2024 GNEN

EXAMINERS AMENDMENT E-MAILED

Jun 4, 2024 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jun 4, 2024 CNEA

ASSIGNED TO EXAMINER

May 28, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 14, 2023 NWOS

NEW APPLICATION ENTERED

Oct 10, 2023 NWAP

Related Trademarks

More from this Owner

SUPERLUMINAL MEDICINES

HYPERLOOP

ADME DRIVE

More in Same Class

MAGIC POWDERS

RELAX RELEAF

HAMYANG KOREAN WILD GINSENG

SBX

ENHANCE